1. Market Research
  2. > Medical Devices
  3. > Medical Equipment and Supply Market Trends
  4. > Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile

Summary

Laboratory Corporation of America Holdings (LabCorp) is a healthcare diagnostics company. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. The company has a network of 39 primary laboratories and more than 1750 patient service centers. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies across all the 50 states in the US, the District of Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

The company focuses on expanding its service portfolio through both inorganic and organic approaches. The inorganic approach includes acquisitions which can be reflected from the recent acquisition of Covance. The organic approach includes in-house development of several testing technologies. These concentrated efforts will help the company gain more market share.

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2010 to YTD 2016 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 12
Laboratory Corporation of America Holdings, Medical Equipment, Deal Details 16
Venture Financing 16
Ativa Medical Raises USD15 Million in Series B Financing 16
Vivify Health Raises Funds in Series B Venture Financing 18
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 20
Flatiron Health Raises US$130 Million In Series B Financing 22
Flatiron Health Raises US$8 Million In Series A Financing 24
Nodality Secures US$15.5 Million In Financing Round 26
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 28
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 30
Partnerships 32
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 32
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 33
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 34
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 35
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 36
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 37
Sysmex Enters into Co-Development Agreement with LabCorp 38
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 39
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 40
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 41
Emdeon Enters Into Strategic Alliance With LabCorp 42
Duke University Medical Center Enters Into Joint Venture With LabCorp 43
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 44
CareDx Terminates Co-Development Agreement with LabCorp 45
University of Minnesota Signs Licensing Agreement With LabCorp 46
Equity Offering 47
LipoScience Completes IPO For US$52 Million 47
Debt Offering 49
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 49
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 51
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 53
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 55
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 57
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 59
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 61
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 63
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 65
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 67
Asset Transactions 69
Marken Acquires European Kit Building Operation Facility From LabCorp 69
Acquisition 70
LabCorp Acquires Covance for USD6.1 Billion 70
LabCorp Acquires Bode Technology from SolutionPoint 73
LabCorp Acquires LipoScience for USD85.3 Million 74
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 76
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 77
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 79
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 80
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 83
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 85
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 86
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 87
Laboratory Corporation of America Holdings - Key Competitors 88
Key Employees 89
Locations And Subsidiaries 90
Head Office 90
Other Locations and Subsidiaries 90
Recent Developments 94
Strategy And Business Planning 94
May 19, 2015: ORIG3N Announces Strategic Collaboration with LabCorp 94
Feb 20, 2015: LabCorp Plans For Cost Savings 95
Financial Announcements 96
Feb 18, 2016: Laboratory Corporation of America Holdings Announces 2015 Fourth Quarter and Full Year Results and Provides 2016 Guidance 96
Oct 26, 2015: Laboratory Corporation of America Holdings Announces 2015 Third Quarter Results 99
Jul 28, 2015: Laboratory Corporation of America Holdings Announces Record 2015 Second Quarter Results and Raises 2015 Adjusted EPS Guidance 102
Apr 27, 2015: Laboratory Corporation of America Holdings Announces 2015 First Quarter Results 105
Feb 20, 2015: Laboratory Corporation of America Holdings Announces 2014 Fourth Quarter and Full Year Results and Provides 2015 Guidance 107
Corporate Communications 109
Jan 07, 2016: LabCorp Announces New Board Member 109
Jan 07, 2016: Richelle Parham Named to the Board of Directors Effective February 8, 2016 110
Jul 28, 2015: LabCorp Announces New Covance Leadership 111
Other Significant Developments 112
Sep 30, 2015: Bode Cellmark Forensics Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide 112
Sep 03, 2015: LabCorp Expands Partnership with Perinatal Quality Foundation to Educate Patients and Healthcare Providers about Noninvasive Prenatal Testing 113
Jul 23, 2015: Covance Opens Fit-for-Purpose Dallas Clinical Research Unit 114
Apr 17, 2015: LabCorp offers eSSENTIAL Accessibility App to Make It Easier for People with Disabilities to Manage Health Care Online 115
Appendix 116
Methodology 116
About GlobalData 116
Contact Us 116
Disclaimer 116

List of Tables
Laboratory Corporation of America Holdings, Medical Equipment, Key Facts, 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Deals By Market, 2010 to YTD 2016 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2010 to YTD 2016 12
Ativa Medical Raises USD15 Million in Series B Financing 16
Vivify Health Raises Funds in Series B Venture Financing 18
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 20
Flatiron Health Raises US$130 Million In Series B Financing 22
Flatiron Health Raises US$8 Million In Series A Financing 24
Nodality Secures US$15.5 Million In Financing Round 26
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 28
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 30
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 32
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 33
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 34
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 35
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 36
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 37
Sysmex Enters into Co-Development Agreement with LabCorp 38
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 39
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 40
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 41
Emdeon Enters Into Strategic Alliance With LabCorp 42
Duke University Medical Center Enters Into Joint Venture With LabCorp 43
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 44
CareDx Terminates Co-Development Agreement with LabCorp 45
University of Minnesota Signs Licensing Agreement With LabCorp 46
LipoScience Completes IPO For US$52 Million 47
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 49
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 51
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 53
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 55
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 57
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 59
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 61
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 63
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 65
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 67
Marken Acquires European Kit Building Operation Facility From LabCorp 69
LabCorp Acquires Covance for USD6.1 Billion 70
LabCorp Acquires Bode Technology from SolutionPoint 73
LabCorp Acquires LipoScience for USD85.3 Million 74
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 76
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 77
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 79
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 80
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 83
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 85
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 86
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 87
Laboratory Corporation of America Holdings, Key Competitors 88
Laboratory Corporation of America Holdings, Key Employees 89
Laboratory Corporation of America Holdings, Other Locations 90
Laboratory Corporation of America Holdings, Subsidiaries 92

List of Figures
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2010 to YTD 2016 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2010 to YTD 2016 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2010 to YTD 2016 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Market, 2010 to YTD 2016 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Disposable Medical Supplies : US Industry Study with Forecasts for 2020 & 2025

Disposable Medical Supplies : US Industry Study with Forecasts for 2020 & 2025

  • $ 5 500
  • Industry report
  • February 2016
  • by Freedonia

A rise in patient activity caused by an aging population, increasing incidence of medical conditions, and extension of health insurance coverage by government programs will promote gains. US demand to ...

Bioactive Wound Care Market Analysis: By First Line Interactive Dressing (Foams, Alginates, Hydrogel, Hydrocolloids, Collagen); By Second Line Interactive Dressing (Honey, Hydrofiber, Silicon, Silver) - With Forecast (2015 - 2020)

Bioactive Wound Care Market Analysis: By First Line Interactive Dressing (Foams, Alginates, Hydrogel, Hydrocolloids, Collagen); By Second Line Interactive Dressing (Honey, Hydrofiber, Silicon, Silver) - With Forecast (2015 - 2020)

  • $ 5 250
  • Industry report
  • February 2016
  • by Industry ARC

The objective of bioactive wound dressings is to reduce the treatment time which will save the overall cost for the patient. The relevance of bioactive wound dressings has increased over the years due ...

Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025

Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025

  • $ 5 000
  • Industry report
  • February 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Future Market Insights (FMI) offers a 10-year forecast of the global infusion pumps market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 5% over the forecast period. ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.